ATE424390T1 - Verfahren zur herstellung von delmopinol und derivaten davon - Google Patents
Verfahren zur herstellung von delmopinol und derivaten davonInfo
- Publication number
- ATE424390T1 ATE424390T1 AT06808580T AT06808580T ATE424390T1 AT E424390 T1 ATE424390 T1 AT E424390T1 AT 06808580 T AT06808580 T AT 06808580T AT 06808580 T AT06808580 T AT 06808580T AT E424390 T1 ATE424390 T1 AT E424390T1
- Authority
- AT
- Austria
- Prior art keywords
- delmopinol
- derivatives
- oxazolidin
- morpholine
- derivative
- Prior art date
Links
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003854 delmopinol Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 4
- 239000007818 Grignard reagent Substances 0.000 abstract 2
- 150000004795 grignard reagents Chemical class 0.000 abstract 2
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 abstract 2
- 229960000649 oxyphenbutazone Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012458 free base Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/02—Magnesium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0523435.6A GB0523435D0 (en) | 2005-11-17 | 2005-11-17 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424390T1 true ATE424390T1 (de) | 2009-03-15 |
Family
ID=35580225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06808580T ATE424390T1 (de) | 2005-11-17 | 2006-11-17 | Verfahren zur herstellung von delmopinol und derivaten davon |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7902357B2 (de) |
| EP (1) | EP1948626B1 (de) |
| JP (1) | JP5202326B2 (de) |
| CN (1) | CN101309913B (de) |
| AT (1) | ATE424390T1 (de) |
| AU (1) | AU2006314309B2 (de) |
| BR (1) | BRPI0618675B1 (de) |
| CA (1) | CA2628921C (de) |
| CY (1) | CY1109049T1 (de) |
| DE (1) | DE602006005513D1 (de) |
| DK (1) | DK1948626T3 (de) |
| ES (1) | ES2321657T3 (de) |
| GB (1) | GB0523435D0 (de) |
| MY (1) | MY143867A (de) |
| NO (1) | NO20082617L (de) |
| NZ (1) | NZ568143A (de) |
| PL (1) | PL1948626T3 (de) |
| PT (1) | PT1948626E (de) |
| RU (1) | RU2404169C2 (de) |
| WO (1) | WO2007057681A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2861199C (en) | 2012-03-20 | 2020-03-24 | Sinclair Pharmaceuticals Limited | Treatment of microbial infections with delmopinol and cetylpyridinium |
| IT201600130642A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo |
| IT201600130729A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione degli intermedi del delmopinolo |
| IT201600130538A1 (it) | 2016-12-23 | 2018-06-23 | Lundbeck Pharmaceuticals Italy S P A | Processo per la produzione del delmopinolo |
| IT201700076821A1 (it) | 2017-08-24 | 2019-02-24 | Lundbeck Pharmaceuticals Italy S P A | Nuovo sale del delmopinolo |
| RU2696099C1 (ru) * | 2019-01-14 | 2019-07-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Хемоэнзиматический синтез производных 2,5-дикетоморфолина |
| WO2021155350A1 (en) * | 2020-01-31 | 2021-08-05 | You First Services, Inc. | Methods of making delmopinol and salts thereof |
| CN112047964A (zh) * | 2020-09-07 | 2020-12-08 | 宋喂 | 格氏试剂制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2507425A1 (de) * | 1975-02-21 | 1976-09-02 | Hoechst Ag | Analoga von prostansaeuren und verfahren zu ihrer herstellung |
| GB1603724A (en) * | 1977-05-25 | 1981-11-25 | Montedison Spa | Components and catalysts for the polymerisation of alpha-olefins |
| SE439011B (sv) * | 1980-03-21 | 1985-05-28 | Ferrosan Ab | Morfolinoforeningar, kompositioner innehallande dessa och anvendning derav |
| FR2561648B1 (fr) * | 1984-03-26 | 1987-08-21 | Hoechst France | Nouvelles perhydro-oxazolo(2,3-c)oxazines-1,4, leur procede de preparation et leur application a l'obtention de glycines substituees |
| US4675369A (en) * | 1984-09-05 | 1987-06-23 | Mobil Oil Corporation | Catalyst composition for polymerizing alpha-olefins at low reactants partial pressures |
| DE69008486T2 (de) * | 1989-05-24 | 1994-09-15 | Pharmacia Ab | Substituierte isoxazolidine und isoxazoline. |
-
2005
- 2005-11-17 GB GBGB0523435.6A patent/GB0523435D0/en not_active Ceased
-
2006
- 2006-11-17 ES ES06808580T patent/ES2321657T3/es active Active
- 2006-11-17 PT PT06808580T patent/PT1948626E/pt unknown
- 2006-11-17 CN CN2006800430395A patent/CN101309913B/zh active Active
- 2006-11-17 NZ NZ568143A patent/NZ568143A/en unknown
- 2006-11-17 AT AT06808580T patent/ATE424390T1/de active
- 2006-11-17 BR BRPI0618675A patent/BRPI0618675B1/pt active IP Right Grant
- 2006-11-17 RU RU2008118067/04A patent/RU2404169C2/ru active
- 2006-11-17 EP EP06808580A patent/EP1948626B1/de active Active
- 2006-11-17 DK DK06808580T patent/DK1948626T3/da active
- 2006-11-17 JP JP2008540690A patent/JP5202326B2/ja active Active
- 2006-11-17 CA CA2628921A patent/CA2628921C/en not_active Expired - Fee Related
- 2006-11-17 AU AU2006314309A patent/AU2006314309B2/en active Active
- 2006-11-17 US US12/092,825 patent/US7902357B2/en active Active - Reinstated
- 2006-11-17 PL PL06808580T patent/PL1948626T3/pl unknown
- 2006-11-17 WO PCT/GB2006/004293 patent/WO2007057681A1/en not_active Ceased
- 2006-11-17 DE DE602006005513T patent/DE602006005513D1/de active Active
-
2008
- 2008-05-06 MY MYPI20081449A patent/MY143867A/en unknown
- 2008-06-12 NO NO20082617A patent/NO20082617L/no not_active Application Discontinuation
-
2009
- 2009-05-06 CY CY20091100486T patent/CY1109049T1/el unknown
-
2010
- 2010-05-13 US US12/779,288 patent/US7910730B2/en active Active
- 2010-12-20 US US12/972,955 patent/US8143463B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1948626B1 (de) | 2009-03-04 |
| PT1948626E (pt) | 2009-05-15 |
| GB0523435D0 (en) | 2005-12-28 |
| RU2008118067A (ru) | 2009-12-27 |
| US20100222579A1 (en) | 2010-09-02 |
| US7910730B2 (en) | 2011-03-22 |
| CA2628921C (en) | 2013-01-08 |
| NZ568143A (en) | 2010-04-30 |
| CY1109049T1 (el) | 2014-07-02 |
| US7902357B2 (en) | 2011-03-08 |
| BRPI0618675B1 (pt) | 2016-03-29 |
| MY143867A (en) | 2011-07-15 |
| JP5202326B2 (ja) | 2013-06-05 |
| BRPI0618675A2 (pt) | 2011-09-06 |
| US20110092751A1 (en) | 2011-04-21 |
| US8143463B2 (en) | 2012-03-27 |
| EP1948626A1 (de) | 2008-07-30 |
| US20090137798A1 (en) | 2009-05-28 |
| ES2321657T3 (es) | 2009-06-09 |
| WO2007057681A1 (en) | 2007-05-24 |
| DK1948626T3 (da) | 2009-05-18 |
| PL1948626T3 (pl) | 2009-08-31 |
| RU2404169C2 (ru) | 2010-11-20 |
| AU2006314309B2 (en) | 2009-12-24 |
| CN101309913B (zh) | 2011-05-25 |
| NO20082617L (no) | 2008-06-12 |
| CA2628921A1 (en) | 2007-05-24 |
| DE602006005513D1 (de) | 2009-04-16 |
| AU2006314309A1 (en) | 2007-05-24 |
| CN101309913A (zh) | 2008-11-19 |
| JP2009516674A (ja) | 2009-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY143867A (en) | Process for the preparation of delmopinol and derivatives thereof | |
| TW200624421A (en) | Method for preparing n-phenylpyrazole-1-carboxamides | |
| ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
| DE60330800D1 (de) | Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen | |
| SG158848A1 (en) | Method for producing annelated piperazin-2-one derivatives and intermediates of said method | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| NO20054614L (no) | Fremgangsmate til fremstilling av 68Ga | |
| TW200500339A (en) | Pyrrolidine derivatives, and process for the preparation | |
| EA200600485A1 (ru) | Способ получения производных 2-оксо-1-пирролидина | |
| NO20073839L (no) | Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette | |
| DE60316152D1 (de) | Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen | |
| WO2008021491A3 (en) | Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| ATE440605T1 (de) | Verfahren zur herstellung von camptothecin- derivaten | |
| EA200501829A1 (ru) | Способ получения непептидных замещённых спиробензоазепиновых производных | |
| ATE546432T1 (de) | Verfahren zur herstellung von 2- aminomethylpyridin-derivate | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| ATE523490T1 (de) | Verfahren zur herstellung von pleuromutilinen | |
| DE60234279D1 (de) | Verfahren zur herstellung eines immunosuppresivums | |
| FR2854402A1 (fr) | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides | |
| ATE423096T1 (de) | Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| HUP0202383A2 (hu) | Eljárás 2-(2-aril-morfolin-il)-etanol-származékok előállítása és közbenső termékek | |
| ATE537160T1 (de) | Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat | |
| ATE466847T1 (de) | Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1948626 Country of ref document: EP |